| |
| |
|
| Insider
Information: |
Wirth Peter |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
373,666 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,052,806 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
373,666 |
|
|
| Total
Value |
$6,052,806 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
-2.0
|
| Percentage
Gain/Loss : |
 -39.0%
|
-64.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Genzyme Corp |
GENZ |
Exec VP,Legal & Corpor... |
2011-04-04 |
0 |
2011-04-04 |
0 |
Premium* |
|
|
Forma Therapeutics Holdings, Inc., |
FMTX |
Director |
2022-10-14 |
0 |
|
0 |
Premium* |
|
|
Zai Lab Ltd |
ZLAB |
|
2023-06-29 |
361,666 |
2022-12-08 |
0 |
Premium* |
|
|
Syros Pharmaceuticals, Inc. |
SYRS |
Director |
2023-06-01 |
12,000 |
2022-09-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ZLAB |
Zai Lab Ltd |
|
– • – |
2023-06-29 |
4 |
A |
$26.45 |
$499,984 |
D/D |
18,903 |
361,666 |
0 |
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
Director |
– • – |
2023-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
12,000 |
0 |
- |
|
| ZLAB |
Zai Lab Ltd |
Director |
– • – |
2022-12-08 |
4 |
S |
$35.33 |
$141,320 |
I/I |
(4,000) |
0 |
0 |
% |
|
| ZLAB |
Zai Lab Ltd |
Director |
– • – |
2022-12-08 |
4 |
S |
$35.37 |
$136,245 |
D/D |
(3,852) |
342,763 |
0 |
% |
|
| FMTX |
Forma Therapeutics Holdin... |
Director |
– • – |
2022-10-14 |
4 |
D |
$0.00 |
$0 |
D/D |
(134,915) |
0 |
0 |
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
Director |
– • – |
2022-09-16 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
8,000 |
0 |
- |
|
| ZLAB |
Zai Lab Ltd |
Director |
– • – |
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
7,763 |
350,615 |
0 |
- |
|
| ZLAB |
Zai Lab Ltd |
Director |
– • – |
2021-12-08 |
4/A |
B |
$71.36 |
$285,440 |
I/I |
4,000 |
4,000 |
2.1 |
- |
|
| ZLAB |
Zai Lab Ltd |
Director |
– • – |
2021-12-08 |
4 |
B |
$71.36 |
$285,440 |
D/D |
4,000 |
342,852 |
2.39 |
% |
|
| FMTX |
Forma Therapeutics Holdin... |
Director |
– • – |
2021-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,750 |
130,415 |
0 |
- |
|
| ZLAB |
Zai Lab Ltd |
Director |
– • – |
2021-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
3,852 |
338,852 |
0 |
- |
|
| ZLAB |
Zai Lab Ltd |
Director |
– • – |
2021-01-01 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
35,000 |
|
- |
|
| ZLAB |
Zai Lab Ltd |
Director |
– • – |
2021-01-01 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
335,000 |
|
- |
|
| FMTX |
Forma Therapeutics Holdin... |
Director |
– • – |
2020-06-23 |
4 |
S |
$0.00 |
$0 |
D/D |
(78,454) |
0 |
0 |
- |
|
| FMTX |
Forma Therapeutics Holdin... |
Director |
– • – |
2020-06-23 |
4 |
B |
$0.00 |
$0 |
D/D |
63,299 |
127,665 |
2.31 |
- |
|
| FMTX |
Forma Therapeutics Holdin... |
Director |
– • – |
2020-06-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
64,366 |
|
- |
|
| FMTX |
Forma Therapeutics Holdin... |
Director |
– • – |
2020-06-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
22,744 |
|
- |
|
| FMTX |
Forma Therapeutics Holdin... |
Director |
– • – |
2020-06-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
14,605 |
|
- |
|
| FMTX |
Forma Therapeutics Holdin... |
Director |
– • – |
2020-06-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,325 |
|
- |
|
| FMTX |
Forma Therapeutics Holdin... |
Director |
– • – |
2020-06-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,332 |
|
- |
|
| FMTX |
Forma Therapeutics Holdin... |
Director |
– • – |
2020-06-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
8,628 |
|
- |
|
| GENZ |
Genzyme Corp |
Exec VP,Legal & Corporate Dev. |
• – – |
2011-04-04 |
4 |
D |
$74.00 |
$10,952 |
I/I |
(148) |
0 |
0 |
- |
|
| GENZ |
Genzyme Corp |
Exec VP,Legal & Corporate Dev. |
• – – |
2011-04-04 |
4 |
D |
$74.00 |
$2,164,500 |
D/D |
(29,250) |
0 |
0 |
- |
|
| GENZ |
Genzyme Corp |
Exec VP,Legal & Corporate Dev. |
• – – |
2011-04-04 |
4 |
D |
$74.00 |
$1,158,840 |
D/D |
(15,660) |
29,250 |
0 |
- |
|
| GENZ |
Genzyme Corp |
Exec VP,Legal & Corporate Dev. |
• – – |
2011-04-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,250 |
44,910 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
